P3.02b-096 Osimertinib (AZD9291) in Asia-Pacific Patients with T790M Mutation-Positive Advanced NSCLC: Open-Label Phase II Study Results
Zhou, Caicun, Wang, Mengzhao, Cheng, Ying, Chen, Yuan, Zhao, Yanqui, Shi, Yuan-Kai, Zhang, He-Long, Ahn, Myung-Ju, Chen, Yajuan, Wang, Jia, Cantarini, Mireille, Wu, Yi LongVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1763
Date:
January, 2017
File:
PDF, 131 KB
english, 2017